CAS: 1371569-69-5
Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
(4-(3-Benzyloxyphenyl)-2-ethylsulfinyl-6-(trifluoroMethyl)pyriMidine REF: IN-DA009ENLCAS: 1371569-69-5 | 97% | 45,00 €~585,00 € | Ter 07 Jan 25 | |
BETP REF: TM-TQ0124CAS: 1371569-69-5 | 97.92% | 47,00 €~661,00 € | Ter 14 Jan 25 | |
(4-(3-Benzyloxyphenyl)-2-ethylsulfinyl-6-(trifluoromethyl)pyrimidine REF: 3D-FB98669CAS: 1371569-69-5 | Min. 95% | A consultar | Ter 18 Fev 25 |
(4-(3-Benzyloxyphenyl)-2-ethylsulfinyl-6-(trifluoroMethyl)pyriMidine
CAS:1371569-69-5
Fórmula:
C20H17F3N2O2S
Pureza:
97%
Cor e Forma:
Solid
Peso molecular:
406.4214
Ref: IN-DA009ENL
1mg | 45,00 € | ||
5mg | 89,00 € | ||
50mg | 216,00 € | ||
100mg | 458,00 € |
Entrega estimada em Estados Unidos, Terça-feira 7 de Janeiro de 2025
BETP
CAS:1371569-69-5
BETP is an agonist of GLP-1 receptor (EC50s: 0.66 and 0.755 μM for human and …
Fórmula:
C20H17F3N2O2S
Pureza:
97.92%
Cor e Forma:
Solid
Peso molecular:
406.42
Ref: TM-TQ0124
1mg | 47,00 € | ||
5mg | 91,00 € | ||
10mg | 137,00 € | ||
25mg | 258,00 € | ||
50mg | 414,00 € | ||
100mg | 661,00 € | ||
1mL*10mM (DMSO) | 96,00 € |
Entrega estimada em Estados Unidos, Terça-feira 14 de Janeiro de 2025
(4-(3-Benzyloxyphenyl)-2-ethylsulfinyl-6-(trifluoromethyl)pyrimidine
CAS:1371569-69-5
4-(3-Benzyloxyphenyl)-2-ethylsulfinyl-6-(trifluoromethyl)pyrimidine is a drug that is used as an insulinotropic agent. It was first synthesized …
Fórmula:
C20H17F3N2O2S
Pureza:
Min. 95%
Peso molecular:
406.42 g/mol
Ref: 3D-FB98669
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar |
Entrega estimada em Estados Unidos, Terça-feira 18 de Fevereiro de 2025